| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;99:2571-2576.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
Retroviral Gene Therapy in ApoE-Deficient Mice
ApoE Expression in the Artery Wall Reduces Early Foam Cell Lesion Formation
From the Departments of Pathology (A.H.H., S.F.), Medicine (M.F.L., S.J.B., V.R.B., L.A.G., S.F.), Pharmacology (M.F.L), Cell Biology (S.J.B), and Veterans Affairs (S.J.B), Vanderbilt University Medical Center, Nashville, Tenn.
Correspondence to Dr Sergio Fazio or Dr MacRae Linton, Division of Endocrinology, Vanderbilt University School of Medicine, 715 Medical Research Building II, Nashville, TN 37232-6303. E-mail sergio.fazio@mcmail.vanderbilt.edu or macrae.linton{at}mcmail.vanderbilt.edu
Background—Apolipoprotein E (apoE) has long been known to play an important role in the clearance of plasma lipoproteins. More recently, a direct role for apoE in delaying atherogenesis has been proposed. Macrophage production of apoE in the artery wall has been demonstrated to provide protection against atherosclerotic lesion development independently from its role in lipoprotein clearance. However, whether macrophage apoE can affect lesion growth at all stages of atherogenesis remains to be established.
Methods and Results—To evaluate the role of macrophage apoE in different stages of atherogenesis, as well as to establish a novel gene therapy approach to atherosclerotic vascular disease, we used an apoE-expressing retrovirus to transduce apoE-deficient (-/-) bone marrow for transplantation into apoE(-/-) recipient mice. Three weeks after bone marrow transplantation, apoE was expressed from arterial macrophages and was detectable in plasma associated with lipoproteins at 0.5% to 1% of normal levels but did not affect plasma cholesterol levels. We used 2 groups of recipient mice: younger mice with lesions consisting primarily of foam cells and older mice with more advanced lesions. When either the mouse or human apoE transgenes were expressed in mice from 5 to 13 weeks of age, there was a significant reduction in lesion area, whereas no effects were detected in mice that expressed apoE from 10 to 26 weeks of age.
Conclusions—We demonstrate that arterial macrophage apoE secretion can delay atherogenesis if expressed during foam cell formation but is not beneficial during the later stages of atherogenesis. These data also provide evidence that apoE transgene expression from arterial macrophages may have therapeutic applications.
Key Words: apolipoproteins • atherosclerosis • genes • cholesterol
This article has been cited by other articles:
 |
|
 |
|
  Y. R. Su, J. L. Blakemore, Y. Zhang, M. F. Linton, and S. Fazio Lentiviral Transduction of ApoAI Into Hematopoietic Progenitor Cells and Macrophages: Applications to Cell Therapy of Atherosclerosis Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1439 - 1446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Atkinson, K. R. Coenen, M. R. Plummer, M. L. Gruen, and A. H. Hasty Macrophage-derived apolipoprotein E ameliorates dyslipidemia and atherosclerosis in obese apolipoprotein E-deficient mice Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E284 - E290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Fan, S. Qiu, C. D. Overton, P. G. Yancey, L. L. Swift, W. G. Jerome, M. F. Linton, and S. Fazio Impaired Secretion of Apolipoprotein E2 from Macrophages J. Biol. Chem., May 4, 2007; 282(18): 13746 - 13753. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Yancey, W. G. Jerome, H. Yu, E. E. Griffin, B. E. Cox, V. R. Babaev, S. Fazio, and M. F. Linton Severely altered cholesterol homeostasis in macrophages lacking apoE and SR-BI J. Lipid Res., May 1, 2007; 48(5): 1140 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Yancey, H. Yu, M. F. Linton, and S. Fazio A Pathway-Dependent on ApoE, ApoAI, and ABCA1 Determines Formation of Buoyant High-Density Lipoprotein by Macrophage Foam Cells Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1123 - 1131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Lucic, Z. H. Huang, D. S. Gu, M. K. Altenburg, N. Maeda, and T. Mazzone Regulation of macrophage apoE secretion and sterol efflux by the LDL receptor J. Lipid Res., February 1, 2007; 48(2): 366 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ranalletta, N. Wang, S. Han, L. Yvan-Charvet, C. Welch, and A. R. Tall Decreased Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice Transplanted With Abcg1-/- Bone Marrow Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2308 - 2315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. H. Huang, M. L. Fitzgerald, and T. Mazzone Distinct Cellular Loci for the ABCA1-Dependent and ABCA1-Independent Lipid Efflux Mediated by Endogenous Apolipoprotein E Expression Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 157 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H. Hasty, M. R. Plummer, K. H. Weisgraber, M. F. Linton, S. Fazio, and L. L. Swift The recycling of apolipoprotein E in macrophages: influence of HDL and apolipoprotein A-I J. Lipid Res., July 1, 2005; 46(7): 1433 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fazio and M. F. Linton Interplay Between Apolipoprotein E and Scavenger Receptor Class B Type I Controls Coronary Atherosclerosis and Lifespan in the Mouse Circulation, June 28, 2005; 111(25): 3349 - 3351. [Full Text] [PDF]
|
|
|
|
|
|
R. L. Raffai, S. M. Loeb, and K. H. Weisgraber Apolipoprotein E Promotes the Regression of Atherosclerosis Independently of Lowering Plasma Cholesterol Levels Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 436 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wientgen, F. E. Thorngate, S. Omerhodzic, L. Rolnitzky, J. T. Fallon, D. L. Williams, and E. A. Fisher Subphysiologic Apolipoprotein E (ApoE) Plasma Levels Inhibit Neointimal Formation After Arterial Injury in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., August 1, 2004; 24(8): 1460 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. W.Q. Moore, B. Zhu, D. G. Kuhel, and D. Y. Hui Vascular Apolipoprotein E Expression and Recruitment from Circulation to Modulate Smooth Muscle Cell Response to Endothelial Denudation Am. J. Pathol., June 1, 2004; 164(6): 2109 - 2116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Y. Ishida, K. R. Bailey, K. G. Duncan, R. J. Chalkley, A. L. Burlingame, J. P. Kane, and D. M. Schwartz Regulated expression of apolipoprotein E by human retinal pigment epithelial cells J. Lipid Res., February 1, 2004; 45(2): 263 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Gough and E. W. Raines Gene therapy of apolipoprotein E-deficient mice using a novel macrophage-specific retroviral vector Blood, January 15, 2003; 101(2): 485 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fazio, V. R. Babaev, M. E. Burleigh, A. S. Major, A. H. Hasty, and M. F. Linton Physiological expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice J. Lipid Res., October 1, 2002; 43(10): 1602 - 1609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bultel-Brienne, S. Lestavel, A. Pilon, I. Laffont, A. Tailleux, J.-C. Fruchart, G. Siest, and V. Clavey Lipid Free Apolipoprotein E Binds to the Class B Type I Scavenger Receptor I (SR-BI) and Enhances Cholesteryl Ester Uptake from Lipoproteins J. Biol. Chem., September 20, 2002; 277(39): 36092 - 36099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Boucher, P. Liu, M. Gotthardt, T. Hiesberger, R. G. W. Anderson, and J. Herz Platelet-derived Growth Factor Mediates Tyrosine Phosphorylation of the Cytoplasmic Domain of the Low Density Lipoprotein Receptor-related Protein in Caveolae J. Biol. Chem., May 3, 2002; 277(18): 15507 - 15513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Harris, I. R. Graham, S. Schepelmann, A. K. Stannard, M. L. Roberts, B. L. Hodges, V. Hill, A. Amalfitano, D. G. Hassall, J. S. Owen, et al. Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1-, E3-, polymerase-] adenovirus vector expressing human apoE Hum. Mol. Genet., January 1, 2002; 11(1): 43 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yoshida, A. H. Hasty, A. S. Major, H. Ishiguro, Y. R. Su, L. A. Gleaves, V. R. Babaev, M. F. Linton, and S. Fazio Isoform-Specific Effects of Apolipoprotein E on Atherogenesis: Gene Transduction Studies in Mice Circulation, December 4, 2001; 104(23): 2820 - 2825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Stannard, D. R. Riddell, S. M. Sacre, A. D. Tagalakis, C. Langer, A. von Eckardstein, P. Cullen, T. Athanasopoulos, G. Dickson, and J. S. Owen Cell-derived Apolipoprotein E (ApoE) Particles Inhibit Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression in Human Endothelial Cells J. Biol. Chem., November 30, 2001; 276(49): 46011 - 46016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Major, D. E. Dove, H. Ishiguro, Y. R. Su, A. M. Brown, L. Liu, K. J. Carter, M. F. Linton, and S. Fazio Increased Cholesterol Efflux in Apolipoprotein AI (ApoAI)-Producing Macrophages as a Mechanism for Reduced Atherosclerosis in ApoAI(-/-) Mice Arterioscler. Thromb. Vasc. Biol., November 1, 2001; 21(11): 1790 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-Y. Lin, Z. H. Huang, and T. Mazzone Interaction with proteoglycans enhances the sterol efflux produced by endogenous expression of macrophage apoE J. Lipid Res., July 1, 2001; 42(7): 1125 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ishimori, K. Iwabuchi, S. Fujii, K. Watano, C. Iwabuchi, M. Ato, H. Chiba, S. Tanaka, A. Kitabatake, and K. Onoé Mixed allogeneic chimerism with wild-type strains ameliorates atherosclerosis in apolipoprotein E-deficient mice J. Leukoc. Biol., May 1, 2001; 69(5): 732 - 740. [Abstract] [Full Text]
|
|
|
|
|
|
J. F. Bentzon, E. Skovenborg, C. Hansen, J. Moller, N. S.-C. de Gaulejac, J. Proch, and E. Falk Red Wine Does Not Reduce Mature Atherosclerosis in Apolipoprotein E-Deficient Mice Circulation, March 27, 2001; 103(12): 1681 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Stein and O. Stein Does Therapeutic Intervention Achieve Slowing of Progression or Bona Fide Regression of Atherosclerotic Lesions? Arterioscler. Thromb. Vasc. Biol., February 1, 2001; 21(2): 183 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Getz Mouse Model of Unstable Atherosclerotic Plaque? Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2503 - 2505. [Full Text] [PDF]
|
|
|
|
|
|
S. Marathe, Y. Choi, A. R. Leventhal, and I. Tabas Sphingomyelinase Converts Lipoproteins From Apolipoprotein E Knockout Mice Into Potent Inducers of Macrophage Foam Cell Formation Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2607 - 2613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Zhu, D. G. Kuhel, D. P. Witte, and D. Y. Hui Apolipoprotein E Inhibits Neointimal Hyperplasia after Arterial Injury in Mice Am. J. Pathol., December 1, 2000; 157(6): 1839 - 1848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. K. Curtiss ApoE in Atherosclerosis : A Protein With Multiple Hats Arterioscler. Thromb. Vasc. Biol., August 1, 2000; 20(8): 1852 - 1853. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sinnaeve, O. Varenne, D. Collen, and S. Janssens Gene therapy in the cardiovascular system: an update Cardiovasc Res, December 1, 1999; 44(3): 498 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Rees, T. Sloane, W. Jessup, R. T. Dean, and L. Kritharides Apolipoprotein A-I Stimulates Secretion of Apolipoprotein E by Foam Cell Macrophages J. Biol. Chem., September 24, 1999; 274(39): 27925 - 27933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ishiguro, H. Yoshida, A. S. Major, T. Zhu, V. R. Babaev, M. F. Linton, and S. Fazio Retrovirus-mediated Expression of Apolipoprotein A-I in the Macrophage Protects against Atherosclerosis in Vivo J. Biol. Chem., September 21, 2001; 276(39): 36742 - 36748. [Abstract] [Full Text] [PDF]
|
|